Here are the three stocks that continue to pass the “stocks to own” screen:
| Ticker | Price | Fair Value | Margin of Safety | Yield % |
| SEP | $42.92 | $50.00 | $7.08 | 6.2% |
| AMGN | $169.27 | $198.00 | $28.73 | 2.5% |
| WMT | $69.95 | $77.00 | $7.05 | 2.9% |
Click on the links to research further.
Results are based on the following screen:
- Low fair value uncertainty.
- Wide moat.
- Morningstar rating 4 or more stars.
- Financial Health Grade >= B.
- Current P/E <= 20.
Amgen looks attractive – but there is a lot of risk involved:
- Zacks – Amgen (AMGN): Repatha Outcomes Data Disappoint, Shares Drop
- Bloomberg Gadfly – There’s a Middle Ground in Amgen’s Drug-Price Battle
Extra – We are number 14 on this list?
- Bloomberg – These Are the 15 Happiest Countries in the World
Leave a Reply